SG11201606843SA - Fusion genes in cancer - Google Patents
Fusion genes in cancerInfo
- Publication number
- SG11201606843SA SG11201606843SA SG11201606843SA SG11201606843SA SG11201606843SA SG 11201606843S A SG11201606843S A SG 11201606843SA SG 11201606843S A SG11201606843S A SG 11201606843SA SG 11201606843S A SG11201606843S A SG 11201606843SA SG 11201606843S A SG11201606843S A SG 11201606843SA
- Authority
- SG
- Singapore
- Prior art keywords
- cancer
- fusion genes
- genes
- fusion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG11201606843SA SG11201606843SA (en) | 2014-03-21 | 2015-03-23 | Fusion genes in cancer |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201400876T | 2014-03-21 | ||
| SG11201606843SA SG11201606843SA (en) | 2014-03-21 | 2015-03-23 | Fusion genes in cancer |
| PCT/SG2015/050047 WO2015142293A1 (en) | 2014-03-21 | 2015-03-23 | Fusion genes in cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201606843SA true SG11201606843SA (en) | 2016-10-28 |
Family
ID=54145081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201606843SA SG11201606843SA (en) | 2014-03-21 | 2015-03-23 | Fusion genes in cancer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20170081723A1 (en) |
| EP (1) | EP3119912A4 (en) |
| JP (1) | JP2017514514A (en) |
| CN (1) | CN106460054A (en) |
| SG (1) | SG11201606843SA (en) |
| WO (1) | WO2015142293A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6762539B2 (en) | 2015-08-24 | 2020-09-30 | アステラス製薬株式会社 | Method for detecting OCRN-ARHGAP26 gene |
| JP6762540B2 (en) * | 2015-08-24 | 2020-09-30 | アステラス製薬株式会社 | Method for detecting the RP2-ARHGAP6 gene |
| US11053553B2 (en) | 2016-08-10 | 2021-07-06 | Astellas Pharma Inc. | Detection of CLDN18-ARHGAP6 fusion gene or CLDN18-ARHGAP26 fusion gene in pancreatic cancer |
| CN106434953B (en) * | 2016-10-27 | 2019-11-22 | 宁波大学 | A kind of detection and application of gastric cancer New molecular marker object hsa_circ_0074362 |
| KR101996141B1 (en) * | 2017-09-21 | 2019-07-03 | 건국대학교 산학협력단 | Composition for diagnosing tumor using BCAR4 exon 4 or its fusion gene thereof |
| WO2020198485A1 (en) * | 2019-03-26 | 2020-10-01 | The Penn State Research Foundation | Methods and materials for treating cancer |
| WO2022114957A1 (en) * | 2020-11-26 | 2022-06-02 | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Personalized tumor markers |
| CN115920053A (en) * | 2022-12-23 | 2023-04-07 | 河北医科大学第四医院 | Application of CRX in diagnosis and treatment of lung cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ562237A (en) * | 2007-10-05 | 2011-02-25 | Pacific Edge Biotechnology Ltd | Proliferation signature and prognosis for gastrointestinal cancer |
| US20100285475A1 (en) * | 2007-10-22 | 2010-11-11 | Agency For Science, Technology And Research | Fused genes |
| KR101824744B1 (en) * | 2009-10-07 | 2018-03-15 | 제넨테크, 인크. | Methods for treating, diagnosing, and monitoring lupus |
| US20120258998A1 (en) * | 2011-04-05 | 2012-10-11 | Patrick Tan | Fusion genes in gastrointestinal cancer |
| US20140296181A1 (en) * | 2011-04-07 | 2014-10-02 | Coferon, Inc. | Methods of modulating oncogenic fusion proteins |
| CA2759516C (en) * | 2011-11-24 | 2019-12-31 | Ibm Canada Limited - Ibm Canada Limitee | Serialization of pre-initialized objects |
| WO2013089882A2 (en) * | 2011-09-27 | 2013-06-20 | The Regents Of The University Of Michigan | Recurrent gene fusions in breast cancer |
| EP2812354A4 (en) * | 2012-02-06 | 2016-03-09 | Univ California | Emp2 regulates angiogenesis in cancer cells through induction of vegf |
| WO2013174403A1 (en) * | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| US10169530B2 (en) * | 2012-11-05 | 2019-01-01 | Genomic Health, Inc. | Gene fusions and alternatively spliced junctions associated with breast cancer |
| CN102993314B (en) * | 2012-12-24 | 2014-04-30 | 河北大学 | Anti-tumor fusion protein, as well as preparation method and application thereof |
-
2015
- 2015-03-23 EP EP15765285.0A patent/EP3119912A4/en not_active Withdrawn
- 2015-03-23 CN CN201580026399.3A patent/CN106460054A/en active Pending
- 2015-03-23 SG SG11201606843SA patent/SG11201606843SA/en unknown
- 2015-03-23 JP JP2017500798A patent/JP2017514514A/en active Pending
- 2015-03-23 WO PCT/SG2015/050047 patent/WO2015142293A1/en active Application Filing
- 2015-03-23 US US15/122,554 patent/US20170081723A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3119912A1 (en) | 2017-01-25 |
| WO2015142293A1 (en) | 2015-09-24 |
| EP3119912A4 (en) | 2018-02-14 |
| CN106460054A (en) | 2017-02-22 |
| US20170081723A1 (en) | 2017-03-23 |
| JP2017514514A (en) | 2017-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274903A (en) | Cell | |
| ZA201704297B (en) | Pyrrolobenzodiazepine-antibody conjugates | |
| PL3119885T3 (en) | Antibody-fynomer conjugates | |
| IL251630A0 (en) | Combination therapy for use in cancer therapy | |
| SG11201606843SA (en) | Fusion genes in cancer | |
| GB201413621D0 (en) | Payment mode selection | |
| GB201418892D0 (en) | DNA editing | |
| GB201512044D0 (en) | Application in German | |
| HK1221760A1 (en) | Heater | |
| IL255560A (en) | Macropinocytosis in cancer | |
| EP3180004A4 (en) | Cancer therapeutics | |
| GB201407755D0 (en) | Nanocrystals | |
| IL246349A0 (en) | Factor vii conjugates | |
| PT3126521T (en) | Hnf4g-rspo2 fusion gene | |
| GB201523035D0 (en) | In terferometry | |
| GB201508480D0 (en) | Cancer | |
| HUE042287T2 (en) | Lithium-sulphur cell | |
| GB2530103B (en) | Rendering geometric shapes | |
| GB201421021D0 (en) | Improvements in luggage | |
| AU5246P (en) | PBA Nasma Vicia faba | |
| GB201419149D0 (en) | Wallet | |
| GB201409311D0 (en) | Colorectal cancer | |
| GB201411884D0 (en) | Cancer therapy | |
| GB201420910D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
| GB201404831D0 (en) | Animalistic studies in nature |